Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Peripheral Guidewires are used during Percutaneous Transluminal Angioplasty (PTA) to guide stents or balloon catheters to the site of blockage in the peripheral vasculature. GlobalData uses proprietary data and analytics to provide a comprehensive report on the peripheral guidewires devices market, including market shares of different players within Australia. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the peripheral guidewires market in Australia was Terumo followed by Abbott Laboratories, Boston Scientific, Cordis, Asahi Intecc, Biotronik SE, Medtronic, Cook Medical and Merit Medical Systems.
Hydrophilic and Non-Hydrophilic Peripheral Guidewires are tracked under Peripheral Guidewires. Hydrophilic Peripheral Guidewires are coated with a hydrophilic coating that provides lubrication and thereby facilitates catheter navigation. Non-Hydrophilic Peripheral Guidewires do not utilize a hydrophilic coating.
The value of the peripheral guidewires devices market within Australia was expected to be over $10m in 2023.
For the latest complete market share analysis of peripheral guidewires device market in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
